We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
7001
CALL
Amkor Technology
AMKR
$13.9B
$184K ﹤0.01%
18,300
-3,300
-15% -$35.3K
CLMT icon
7002
CALL
Calumet Specialty Products
CLMT
$3.59B
$184K ﹤0.01%
23,900
-6,300
-21% -$52.5K
FENG
7003
Phoenix New Media
FENG
$18.3M
$184K ﹤0.01%
+4,727
New +$176K
IDT icon
7004
PUT
IDT Corp
IDT
$1.67B
$184K ﹤0.01%
+20,567
New +$225K
LUMO
7005
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$184K ﹤0.01%
2,522
-845
-25% -$69.9K
RPT
7006
PUT
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$184K ﹤0.01%
+12,500
New +$173K
REGI
7007
DELISTED
Renewable Energy Group, Inc.
REGI
$184K ﹤0.01%
15,601
-3,452
-18% -$39.9K
NSU
7008
PUT
DELISTED
Nevsun Resources Ltd.
NSU
$184K ﹤0.01%
75,600
+15,400
+26% +$35.6K
GORO icon
7009
Goldgroup Mining Inc.
GORO
$167M
$183K ﹤0.01%
41,460
+4,721
+13% +$18.5K
GSS
7010
DELISTED
Golden Star Resources Ltd.
GSS
$183K ﹤0.01%
41,114
+36,596
+810% +$148K
TAHO
7011
CALL
DELISTED
Tahoe Resources Inc
TAHO
$183K ﹤0.01%
38,300
-6,400
-14% -$30.1K
OMED
7012
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$183K ﹤0.01%
44,578
+10,991
+33% +$47.8K
VNDA icon
7013
PUT
Vanda Pharmaceuticals
VNDA
$320M
$182K ﹤0.01%
+12,000
New +$178K
WPRT
7014
CALL
Westport Fuel Systems
WPRT
$34.2M
$182K ﹤0.01%
4,830
+710
+17% +$23.1K
ABEO icon
7015
PUT
Abeona Therapeutics
ABEO
$388M
$181K ﹤0.01%
456
-24
-5% -$9.93K
CORN icon
7016
PUT
Teucrium Corn Fund
CORN
$169M
$181K ﹤0.01%
10,800
-3,500
-24% -$59.7K
RAIL icon
7017
PUT
FreightCar America
RAIL
$281M
$181K ﹤0.01%
+10,600
New +$183K
RFP
7018
CALL
DELISTED
Resolute Forest Products Inc.
RFP
$181K ﹤0.01%
+16,400
New +$133K
CHI
7019
Calamos Convertible Opportunities and Income Fund
CHI
$1.05B
$180K ﹤0.01%
+16,107
New +$185K
TRIL
7020
DELISTED
Trillium Therapeutics Inc.
TRIL
$180K ﹤0.01%
+24,622
New +$204K
ORBC
7021
PUT
DELISTED
ORBCOMM, Inc.
ORBC
$180K ﹤0.01%
+17,700
New +$187K
BKS
7022
CALL
DELISTED
Barnes & Noble
BKS
$179K ﹤0.01%
26,700
-3,600
-12% -$25.5K
KEG
7023
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$179K ﹤0.01%
+15,171
New +$168K
IAU icon
7024
iShares Gold Trust
IAU
$63.3B
$178K ﹤0.01%
+7,100
New +$174K
MRCC
7025
DELISTED
Monroe Capital Corp
MRCC
$178K ﹤0.01%
12,922
+2,855
+28% +$40.9K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.